ArticleMedicine2026
Development and validation of a multimodal ultrasound-mammography model for predicting axillary lymph node metastasis in clinical Tl breast cancer.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
With the global expansion of breast cancer screening, early-stage detection, particularly clinical stage T1 breast cancer, has become increasingly common. Accurate prognosis for T1 cancer is closely linked to lymph node metastasis status. While breast ultrasound and mammography are standard for screening, they are suboptimal for axillary lymph node assessment. This study aimed to predict lymph node metastasis by analyzing primary tumor imaging characteristics. We retrospectively analyzed 148 patients with pathologically confirmed stage T1 breast cancer. Multivariate logistic regression identified independent risk factors for lymph node metastasis from breast ultrasound and mammography features. Subsequently, a line graph model was established to predict axillary lymph node metastasis. A predictive nomogram was developed and validated, demonstrating good discrimination with area under the receiver operating characteristic curve of 0.78 (training set) and 0.72 (validation set). The model also showed favorable calibration and clinical utility via decision curve analysis. In conclusion, this model can provide risk stratification for clinical T1-stage breast cancer axillary lymph node metastasis, which to some extent aids clinical decision-making, thereby reducing missed diagnoses and unnecessary invasive procedures. However, further prospective validation is still required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.